Cognition Therapeutics
CGTX
75 hedge funds and large institutions have $16.3M invested in Cognition Therapeutics in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 14 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.38% less ownership
Funds ownership: 24.35% → 23.97% (-0.38%)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
4% less funds holding
Funds holding: 78 → 75 (-3)
44% less capital invested
Capital invested by funds: $29M → $16.3M (-$12.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$233K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$185K |
| 3 |
HF
HRT Financial
New York
|
+$178K |
| 4 |
Renaissance Technologies
New York
|
+$172K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$142K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$284K |
| 2 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$215K |
| 3 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$205K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$157K |
| 5 |
VC
Voss Capital
Houston,
Texas
|
-$92.4K |
CGTX Hedge Fund Activity: Q1 2026 in Review
75 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q1 2026, worth a combined $16.3M — down 44% from $29M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CGTX and 13 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 18 added.
The largest buyer was CM Management, adding an estimated $233K. The largest seller was Jane Street, cutting an estimated $284K.
- 75 institutional investors held Cognition Therapeutics (CGTX) as of Q1 2026, down from 78 in Q4 2025.
- Funds reported $16.3M of Cognition Therapeutics stock for Q1 2026, down 44% quarter-over-quarter.
- 13 funds opened new Cognition Therapeutics positions in Q1 2026 and 14 closed out, a net change of -1 holder.
- The largest Cognition Therapeutics buyer in Q1 2026 was CM Management, an estimated $233K added.
- The largest Cognition Therapeutics seller in Q1 2026 was Jane Street, an estimated $284K sold.
Based on aggregated 13F filings for Q1 2026.